Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

被引：17

作者：

Menzel, Michael ^{[1
,2
]}

Ossowski, Stephan ^{[3
,4
,5
]}

Kral, Sebastian ^{[6
,7
]}

Metzger, Patrick ^{[7
,8
]}

Horak, Peter ^{[2
,9
,10
]}

Marienfeld, Ralf ^{[11
,12
]}

Boerries, Melanie ^{[7
,8
,13
,14
]}

Wolter, Steffen ^{[6
,7
]}

Ball, Markus ^{[1
,2
]}

Neumann, Olaf ^{[1
,2
]}

Armeanu-Ebinger, Sorin ^{[3
,4
]}

Schroeder, Christopher ^{[3
,4
]}

Matysiak, Uta ^{[6
,7
]}

Goldschmid, Hannah ^{[1
,2
]}

Schipperges, Vincent ^{[7
,8
]}

Fuerstberger, Axel ^{[11
,12
,15
]}

Allgaeuer, Michael ^{[1
,2
]}

Eberhardt, Timo ^{[11
,12
]}

Niewoehner, Jakob ^{[11
]}

Blaumeiser, Andreas ^{[7
,8
,14
]}

Ploeger, Carolin ^{[1
,2
]}

Haack, Tobias Bernd ^{[3
,4
]}

Tay, Timothy Kwang Yong ^{[1
,2
,16
]}

Kelemen, Olga ^{[3
,4
]}

Pauli, Thomas ^{[7
,8
]}

Kirchner, Martina ^{[1
,2
]}

Kluck, Klaus ^{[1
,2
]}

Ott, Alexander ^{[3
,4
]}

Renner, Marcus ^{[1
,2
,9
]}

Admard, Jakob ^{[3
,4
]}

Gschwind, Axel ^{[3
,4
]}

Lassmann, Silke ^{[6
,7
]}

Kestler, Hans ^{[11
,12
]}

Fend, Falko ^{[17
]}

Illert, Anna Lena ^{[18
,19
,20
]}

Werner, Martin ^{[6
,7
,14
]}

Moeller, Peter ^{[11
]}

Seufferlein, Thomas Theodor Werner ^{[12
,21
]}

Malek, Nisar ^{[4
,22
]}

Schirmacher, Peter ^{[1
,2
,10
]}

Froehling, Stefan ^{[2
,9
,10
]}

Kazdal, Daniel ^{[1
,2
]}

Budczies, Jan ^{[1
,2
,10
]}

Stenzinger, Albrecht ^{[1
,2
,10
]}

机构：

[1] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany

[2] Ctr Personalized Med ZPM, Heidelberg, Germany

[3] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany

[4] Ctr Personalized Med ZPM, Tubingen, Germany

[5] Univ Tubingen, Inst Bioinformat & Med Informat IBMI, Tubingen, Germany

[6] Univ Freiburg, Inst Surg Pathol, Med Ctr, Freiburg, Germany

[7] Ctr Personalized Med ZPM, Freiburg, Germany

[8] Univ Freiburg, Freiburg Univ Med Ctr, Inst Med Bioinformat & Syst Med IBSM, Fac Med, Freiburg, Germany

[9] Heidelberg & German Canc Res Ctr DKFZ, Natl Ctr Tumor Dis NCT, Div Translat Med Oncol, D-69120 Heidelberg, Germany

[10] German Canc Consortium DKTK, Heidelberg, Germany

[11] Univ Hosp Ulm, Inst Pathol, Ulm, Germany

[12] Ctr Personalized Med ZPM, Ulm, Germany

[13] Univ Freiburg, Fac Med, Comprehens Canc Ctr Freiburg CCCF, Med Ctr, Freiburg, Germany

[14] German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Partner Site Freiburg, Heidelberg, Germany

[15] Ulm Univ, Inst Med Syst Biol, Ulm, Germany

[16] Singapore Gen Hosp, Dept Anat Pathol, Singapore, Singapore

[17] Univ Hosp Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany

[18] Univ Freiburg, Fac Med, Med Ctr, Dept Radiol,Med Phys, D-79085 Freiburg, Germany

[19] Tech Univ Munich, Klinikum Rechts Isar, Nukl Med Klin & Poliklin, D-81675 Munich, Germany

[20] German Canc Consortium DKTK, Partner Site Munich & German Canc Res Ctr DKFZ, Heidelberg, Germany

[21] Univ Hosp Ulm, Dept Internal Medicine1, Ulm, Germany

[22] Univ Hosp Tubingen, Dept Internal Med, Tubingen, Germany

来源：

NPJ PRECISION ONCOLOGY | 2023年 / 7卷 / 01期

关键词：

COPY NUMBER; PERSONALIZED MEDICINE; TUMOR; GENOMICS; ONCOLOGY;

D O I：

10.1038/s41698-023-00457-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A growing number of druggable targets and national initiatives for precision oncology necessitate broad genomic profiling for many cancer patients. Whole exome sequencing (WES) offers unbiased analysis of the entire coding sequence, segmentation-based detection of copy number alterations (CNAs), and accurate determination of complex biomarkers including tumor mutational burden (TMB), homologous recombination repair deficiency (HRD), and microsatellite instability (MSI). To assess the inter-institution variability of clinical WES, we performed a comparative pilot study between German Centers of Personalized Medicine (ZPMs) from five participating institutions. Tumor and matched normal DNA from 30 patients were analyzed using custom sequencing protocols and bioinformatic pipelines. Calling of somatic variants was highly concordant with a positive percentage agreement (PPA) between 91 and 95% and a positive predictive value (PPV) between 82 and 95% compared with a three-institution consensus and full agreement for 16 of 17 druggable targets. Explanations for deviations included low VAF or coverage, differing annotations, and different filter protocols. CNAs showed overall agreement in 76% for the genomic sequence with high wet-lab variability. Complex biomarkers correlated strongly between institutions (HRD: 0.79-1, TMB: 0.97-0.99) and all institutions agreed on microsatellite instability. This study will contribute to the development of quality control frameworks for comprehensive genomic profiling and sheds light onto parameters that require stringent standardization.

引用

页数：11

共 50 条

[1] Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients
Michael Menzel
Stephan Ossowski
Sebastian Kral
Patrick Metzger
Peter Horak
Ralf Marienfeld
Melanie Boerries
Steffen Wolter
Markus Ball
Olaf Neumann
Sorin Armeanu-Ebinger
Christopher Schroeder
Uta Matysiak
Hannah Goldschmid
Vincent Schipperges
Axel Fürstberger
Michael Allgäuer
Timo Eberhardt
Jakob Niewöhner
Andreas Blaumeiser
Carolin Ploeger
Tobias Bernd Haack
Timothy Kwang Yong Tay
Olga Kelemen
Thomas Pauli
Martina Kirchner
Klaus Kluck
Alexander Ott
Marcus Renner
Jakob Admard
Axel Gschwind
Silke Lassmann
Hans Kestler
Falko Fend
Anna Lena Illert
Martin Werner
Peter Möller
Thomas Theodor Werner Seufferlein
Nisar Malek
Peter Schirmacher
Stefan Fröhling
Daniel Kazdal
Jan Budczies
Albrecht Stenzinger
npj Precision Oncology, 7
[2] Whole Exome Sequencing (WES): A Pilot Study in Young Women with Breast Cancer
Collins, L. C.
Wagle, N.
Gelber, S.
Larsen, B.
Ruddy, K.
White, S.
Brachtel, E.
Schapira, L.
Come, S. E.
Borges, V.
Warner, E.
Winer, E.
Partridge, A.
MODERN PATHOLOGY, 2014, 27 : 42A - 42A
[3] Whole Exome Sequencing (WES): A Pilot Study in Young Women with Breast Cancer
Collins, L. C.
Wagle, N.
Gelber, S.
Larsen, B.
Ruddy, K.
White, S.
Brachtel, E.
Schapira, L.
Come, S. E.
Borges, V.
Warner, E.
Winer, E.
Partridge, A.
LABORATORY INVESTIGATION, 2014, 94 : 42A - 42A
[4] Whole genome sequencing (WGS), whole exome sequencing (WES) and clinical exome sequencing (CES) in patient care
Klein, Hanns-Georg
Bauer, Peter
Hambuch, Tina
LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2014, 38 (04): : 221 - 230
[5] Cardiomyopathies (CMs): from clinical characterization to Whole Exome Sequencing (WES) analysis in Italian patients
Alessandrini, Beatrice
Lenarduzzi, Stefania
Dal Ferro, Matteo
Paldino, Alessia
Sinagra, Gianfranco
Gasparini, Paolo
Girotto, Giorgia
EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 138 - 138
[6] Whole exome sequencing (WES) to define the genomic landscape of young lung cancer patients (pts).
Wu, Xiaoliang
Chen, Yanwen
Zhu, Lin
Stylianou, Eleni
Barnholtz-Sloan, Jill
Zhang, Zhenfeng
Ma, Patrick C.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[7] Diagnosis of Williams Syndrome by Whole Exome Sequencing (WES)
Tilemis, Faidon-Nikolaos
Veltra, Danai
Marinakis, Nikolaos
Svingou, Maria
Kosma, Konstantina
Traeger-Synodinos, Jan
Sofocleous, Christalena
EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 202 - 202
[8] Whole exome sequencing (WES) reveals novel therapeutic targets in cervical cancer
Lopez, S.
Han, C.
Altwerger, G.
Menderes, G.
Zammataro, L.
Bellone, S.
Bianchi, A.
Zeybek, B.
Ratner, E. S.
Schwartz, P. E.
Santin, A. D.
GYNECOLOGIC ONCOLOGY, 2019, 154 : 61 - 62
[9] BLOOD DIFFERENTIALS AND WHOLE EXOME SEQUENCING (WES) OF PATIENTS WITH JUVENILE DERMATOMYOSITIS (JDM)
Zhou, Danlei
Coss, Samantha
Aziz, Rabheh Abdul
Miller, Katherine
Al Ahmed, Ohoud
Sivaraman, Vidya
Akoghlanian, Shoghik
Oberle, Edward
Drew, Joanne
Driest, Kyla
Ardoin, Stacy P.
Spencer, Charles
Yu, Chack-Yung
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 528 - 528
[10] Aggregated analysis of integrated whole exome (WES) and whole transcriptome (WTS) sequencing in 1,000 cancer patients
Chernyshov, K.
Love, A.
Rumyantsev, K.
Senichkin, V.
Sagaradze, G.
Polyakova, Z.
Shiotsu, Y.
Clayton, P.
Postovalova, E.
Kotlov, N.
Ogloblina, A.
Bagaev, A.
Fowler, N.
ANNALS OF ONCOLOGY, 2024, 35 : S1360 - S1360

← 1 2 3 4 5 →